Recruiting for diversity in immunotherapy trials for breast and gynecologic cancers: moving beyond under-representation

Int J Gynecol Cancer. 2021 Nov;31(11):1408-1409. doi: 10.1136/ijgc-2021-003088. Epub 2021 Sep 22.

Authors

Travis T Sims¹, Amir A Jazaeri²

Affiliations

¹ Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA aajazaeri@mdanderson.org.

PMID: 34551893
DOI: 10.1136/ijgc-2021-003088

No abstract available

Keywords: cervical cancer; ovarian cancer; uterine cancer.

Publication types

Editorial
Comment

MeSH terms

Female
Genital Neoplasms, Female* / therapy
Humans
Immunotherapy